431 results on '"Ravera, Mauro"'
Search Results
2. Study on the activation of cell death mechanisms: in search of new therapeutic targets in glioblastoma multiforme
3. Freshening Up Old Methods for New Students: A Colorful Laboratory Experiment to Measure the Formation Constants of Ni(II) Complexes Containing Ethane-1,2-Diamine
4. Role of Metal Ions in Dopamine Oxidation
5. A Phyto-mycotherapeutic Supplement, Namely Ganostile, as Effective Adjuvant in Brain Cancer Management: An In Vitro Study Using U251 Human Glioblastoma Cell Line
6. Formulations of highly antiproliferative hydrophobic Pt(IV) complexes into lipidic nanoemulsions as delivery vehicles
7. Unraveling Novel Strategies in Mesothelioma Treatments Using a Newly Synthetized Platinum(IV) Compound.
8. Comprehensive Investigation of [Fe(EDTA)]−‑Functionalized Derivatives and their Supramolecular Adducts with Human Serum Albumin.
9. Retraction of “Pt(IV) Bifunctional Prodrug Containing 2-(2-Propynyl)octanoato Axial Ligand: Induction of Immunogenic Cell Death on Colon Cancer”
10. New Platinum-Based Prodrug Pt(IV)Ac-POA: Antitumour Effects in Rat C6 Glioblastoma Cells
11. A step towards development of promising trypanocidal agents: Synthesis, characterization and in vitro biological evaluation of ferrocenyl Mannich base-type derivatives
12. Comprehensive Investigation of [Fe(EDTA)]−-Functionalized Derivatives and their Supramolecular Adducts with Human Serum Albumin
13. Hybrid inorganic (nonporous silica)/organic (alginate) core-shell platform for targeting a cisplatin-based Pt(IV) anticancer prodrug
14. Effects of Ferrocene and Ferrocenium on MCF-7 Breast Cancer Cells and Interconnection with Regulated Cell Death Pathways
15. Organometallic compounds in the discovery of new agents against kinetoplastid-caused diseases
16. May glutamine addiction drive the delivery of antitumor cisplatin-based Pt(IV) prodrugs?
17. Editorial: The role of platinum-based antitumor prodrugs in medicinal inorganic chemistry
18. Anthracene-terpyridine metal complexes as new G-quadruplex DNA binders
19. Prediction of logP for Pt(II) and Pt(IV) complexes: Comparison of statistical and quantum-chemistry based approaches
20. The inhibitory effects of platinum(II) complexes on amyloid aggregation: a theoretical and experimental approach.
21. Platinum(IV) combo prodrugs containing cyclohexane-1R,2R-diamine, valproic acid, and perillic acid as a multiaction chemotherapeutic platform for colon cancer
22. Image-Guided Nanodelivery of Pt(IV) Prodrugs to GRP-Receptor Positive Tumors
23. The inhibitory effects of platinum (II) complexes on amyloid aggregation: a theoretical and experimental approach
24. Functional fluorescent nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs
25. Application of microwave-assisted heating to the synthesis of Pt(II) complexes
26. Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs
27. Host–guest inclusion systems of Pt(IV)-bis(benzoato) anticancer drug candidates and cyclodextrins
28. Electrochemical studies of Ru(II) diimine bioconjugates
29. The Strange Case: The Unsymmetric Cisplatin-Based Pt(IV) Prodrug [Pt(CH3COO)Cl2(NH3)2(OH)] Exhibits Higher Cytotoxic Activity with respect to Its Symmetric Congeners due to Carrier-Mediated Cellular Uptake
30. The power of a novel combined anticancer therapy: challenge and opportunity of micotherapy in the treatment of Glioblastoma Multiforme
31. Biological activity of a series of cisplatin-based aliphatic bis(carboxylato) Pt(IV) prodrugs: How long the organic chain should be?
32. Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells
33. Supplementary information ijms-1754799
34. Microwave-Assisted Synthesis: Can Transition Metal Complexes Take Advantage of This “Green” Method?
35. Metallo-drugs in the treatment of malignant pleural mesothelioma
36. Access network technologies
37. Evolutionary paths and scenarios
38. Synthesis, characterization, structure, molecular modeling studies and biological activity of sterically crowded Pt(II) complexes containing bis(imidazole) ligands
39. Application of the anthraquinone drug rhein as an axial ligand in bifunctional Pt(iv) complexes to obtain antiproliferative agents against human glioblastoma cells
40. Pt(iv) antitumor prodrugs: dogmas, paradigms, and realities
41. The Strange Case: The Unsymmetric Cisplatin-Based Pt(IV) Prodrug [Pt(CH3COO)Cl2(NH3)2(OH)] Exhibits Higher Cytotoxic Activity with respect to Its Symmetric Congeners due to Carrier-Mediated Cellular Uptake.
42. Antiproliferative activity and inhibition of cancer cell migration by a cisplatin-based Pt(IV) bifunctional prodrug containing perillic acid
43. Tuning photophysical properties with ancillary ligands in Ru(II) mono-diimine complexes
44. Functionalized thymidine derivatives as carriers for the γ-emitter technetium tricarbonyl moiety
45. Poly(methylmetacrylate) (PMMA) core–shell nanospheres act as efficient pharmacophores for the antiproliferative [PtCl 3(NH 3)] − complex by forming ionic couples
46. Electrochemical evaluation of the interaction between antitumoral titanocene dichloride and biomolecules
47. Study of the synthesis, antiproliferative properties, and interaction with DNA and polynucleotides of cisplatin-like Pt(II) complexes containing carcinogenic polyaromatic amines
48. Unsymmetric Cisplatin-Based Pt(IV) Conjugates Containing a PARP-1 Inhibitor Pharmacophore Tested on Malignant Pleural Mesothelioma Cell Lines
49. Can the Self-Assembling of Dicarboxylate Pt(IV) Prodrugs Influence Their Cell Uptake?
50. Molecular and statistical modeling of reduction peak potential and lipophilicity of platinum(IV) complexes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.